ClinicalTrials.gg
Not yet recruitingNCT07761260Updated Aug 12, 2026

BSPTS and Core Stabilization Exercises in Adolescents With Idiopathic Scoliosis

An interventional study of BSPTS Plus Core Stabilization Exercise and BSPTS Exercise in Scoliosis Idiopathic Adolescent, sponsored by Istinye University. Not yet recruiting. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Istinye University · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
10 Years to 18 Years
Sex
All
01

Study summary

This study aims to investigate the short-term effects of adding core stabilization exercises to Barcelona Scoliosis Physical Therapy School (BSPTS) exercises in adolescents with idiopathic scoliosis. Participants will be randomly assigned to either a BSPTS exercise group or a BSPTS plus core stabilization exercise group. Both groups will participate in supervised exercise sessions twice a week for 6 weeks. The study will evaluate changes in trunk rotation angle and core muscle endurance as the primary outcomes, as well as dynamic balance, spinal appearance perception, postural awareness, and scoliosis-related quality of life.

02

Conditions studied

  • Scoliosis Idiopathic Adolescent

Browse trials for

Keywords

  • Adolescent Idiopathic Scoliosis
  • Barcelona Scoliosis Physical Therapy School
  • Core Stabilization Exercises
  • Trunk Rotation Angle
  • Core Muscle Endurance
  • Dynamic Balance
  • Postural Awareness
03

In context

Scoliosis

660 studies on the registry are indexed under Scoliosis; 186 are open to participants now.

This study's planned enrollment of 36 is below the median of 45 across 386 interventional studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Istinye University is the lead sponsor of 221 studies on the registry; 93 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of adolescent idiopathic scoliosis.
  • Cobb angle between 10° and 40°.
  • Risser sign between 0 and 3.
  • Ability to understand and perform the exercise instructions.
  • Willingness to participate in the study and provision of .

Exclusion criteria

Exclusion Criteria:

  • Scoliosis associated with congenital, neuromuscular, or syndromic conditions.
  • Previous spinal surgery.
  • Presence of significant lower-extremity deformity or neurological disorder affecting balance or exercise performance.
  • Current participation in another scoliosis-specific exercise program.
  • Severe cardiopulmonary or systemic disease contraindicating exercise.
  • Inability to complete the assessment procedures or exercise program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    BSPTS Plus Core Stabilization Exercise Group

    Other: BSPTS Plus Core Stabilization Exercise

  • Active comparator
    BSPTS Exercise Group

    Other: BSPTS Exercise

Interventions

  • OtherBSPTS Plus Core Stabilization Exercise

    Participants will receive the same BSPTS-based scoliosis-specific exercise program, combined with core stabilization exercises targeting activation of the transversus abdominis, multifidus, and other deep trunk muscles. Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.

  • OtherBSPTS Exercise

    Participants will receive a Barcelona Scoliosis Physical Therapy School (BSPTS)-based scoliosis-specific exercise program. The program will include three-dimensional self-correction exercises focusing on spinal elongation, derotation, and sagittal plane alignment. Sessions will be conducted under the supervision of a physiotherapist for 45 minutes, twice weekly for 6 weeks.

06

What researchers measure

Primary outcomes

  1. Trunk Rotation Angle

    Trunk rotation angle measured using a scoliometer during the Adams Forward Bend Test.

    Time frame: Baseline and immediately after the 6-week intervention.

  2. Core Muscle Endurance

    Core muscle endurance assessed using the McGill Core Endurance Test Battery, including trunk flexor, trunk extensor, and right and left lateral plank tests.

    Time frame: Baseline and immediately after the 6-week intervention.

Secondary outcomes

  1. Dynamic Balance

    Dynamic balance assessed using the Y-Balance Test.

    Time frame: Baseline and immediately after the 6-week intervention.

  2. Spinal Appearance Perception

    Spinal appearance perception assessed using the Spinal Appearance Questionnaire (SAQ).

    Time frame: Baseline and immediately after the 6-week intervention.

  3. Postural Awareness

    Postural awareness assessed using the Postural Awareness Scale (PAS).

    Time frame: Baseline and immediately after the 6-week intervention.

  4. Scoliosis-Related Quality of Life

    Quality of life, functional status, and psychosocial impact assessed using the Scoliosis Research Society-22 (SRS-22) questionnaire.

    Time frame: Baseline and immediately after the 6-week intervention.

  5. Global Perceived Change

    Perceived change following treatment assessed using the Global Rating of Change Scale.

    Time frame: Immediately after the 6-week intervention.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Mar 2027, 7 months later.

Of 223 non-industry interventional studies with no phase under Scoliosis, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 58. This study's planned 7 months is below that.

Counting every sponsor, half of 233 studies reached it within 22 months; a quarter within 8 and three quarters within 60.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 8, 2026
First posted
Aug 12, 2026
StartEst.
Aug 20, 2026
Primary completionEst.
Mar 25, 2027
CompletionEst.
Mar 25, 2027
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07761260
Lead sponsor
Istinye University
Responsible party
Yunus Emre Tutuneken (Dr. Assistant Professor, Istinye University) — Principal investigator
First posted
Aug 12, 2026
Start date
Aug 20, 2026 (estimated)
Primary completion
Mar 25, 2027 (estimated)
Completion
Mar 25, 2027 (estimated)
Last update
Aug 12, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion